Closed
10.04 -1.38
24h
Min
9.91
Max
10.14
Income | -14M -38M |
---|---|
Sales | -639K 25M |
EPS | -0.8 |
Profit margin | -152.705 |
Employees | 235 |
EBITDA | -16M -31M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +233.43% upside |
Next Earnings | 12 May 2025 |
---|
Market Cap | 27M 446M |
---|---|
Previous open | 11.42 |
Previous close | 10.04 |
By Trading Central
Confidence
Weak Bullish Evidence
Past performance is not a reliable indicator of future results.
Price change
By TipRanks
12 Months Forecast
Average 33.71 USD 233.43%
High 55 USD
Low 16 USD
Based on 7 Wall Street analysts offering 12 month price targets forUroGen Pharma Ltd - Dist in the last 3 months.
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$